Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype

There is a high and rising prevalence of prostate cancer (PRCA) within the male population of the United Kingdom. Although the relative risk of PRCA is higher in male BRCA2 and BRCA1 mutation carriers, the histological characteristics of this malignancy in these groups have not been clearly defined....

Descripción completa

Detalles Bibliográficos
Autores principales: Mitra, A, Fisher, C, Foster, C S, Jameson, C, Barbachanno, Y, Bartlett, J, Bancroft, E, Doherty, R, Kote-Jarai, Z, Peock, S, Easton, D, Eeles, R
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Genetics and Genomics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361443/
https://www.ncbi.nlm.nih.gov/pubmed/18182994
http://dx.doi.org/10.1038/sj.bjc.6604132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361443/
https://www.ncbi.nlm.nih.gov/pubmed/18182994
http://dx.doi.org/10.1038/sj.bjc.6604132

Ejemplares similares